With respect to the potential involvement of OX40-OX40L interactions in the activation of T cells, it has been suggested as a potential therapeutic target for autoimmunity; moreover, effector T cells are major players of MS etiopathogenesis. This evidence concerns the gene TNFRSF4 and myeloid sarcoma.